Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: Contract/Agreement

Ology Bioservices Awarded $37 Million by Department of Defense for Advanced Development of Anti-COVID-19 Monoclonal Antibody Cocktail


Ology Bioservices Inc. (Ology Bio), a biologics contract development and manufacturing organization (CDMO), announced today that the Department of Defense (DOD) has awarded the company with an agreement valued at $37 million. This work is supported by the Office of the Assistant Secretary of Defense for Health Affairs with funding from the Defense Health Agency.

The scope of this program includes the activities required to rapidly develop, manufacture, and obtain FDA licensure of a monoclonal antibody (mAb) cocktail (ADM03820) that was originally identified in a previous agreement with the DOD. The regulatory strategy will outline the manufacturing process characterization and validation activities required to support the initial Biologics License Application (BLA) filing and ultimately marketing of ADM03820. In addition, Ology Bio will support the DOD with a request for an Emergency Use Authorization (EUA) and/or Expanded Access (EA) of ADM03820 for at-risk military personnel.

"This award will allow Ology Bio to extend our rapid development and manufacturing capabilities by introducing the critical regulatory component," said Peter H. Khoury, Ph.D., President and Chief Executive Officer of Ology Bio.

About Ology Bioservices Inc.

Ology Bio is a privately held, full-service Contract Development Manufacturing Organization (CDMO) serving both government and commercial clients, specializing in biologic drug substance manufacturing, from early stage through commercial product. The company has 183,000 square feet of manufacturing, process development and QA/QC space in its state-of-the-art Advanced Development and Manufacturing Facility in Florida. The company's infrastructure provides unique services to its clients, including full regulatory support from preclinical through licensure, clinical trial operational support and bioanalytical testing, as well as CGMP manufacturing up to Biosafety Level 3 (BSL3). Ology Bio has more than 20 years' experience developing and manufacturing drugs and biologics for the U.S. government, with more than $1.8 billion in government contracts awarded. The team at Ology Bio has decades of experience manufacturing, developing and licensing vaccines and protein/antibody therapeutics. For more information, visit the company's website at www.ologybio.com.

[The information contained in this press release does not necessarily reflect the position or the policy of the U.S. government and no official endorsement should be inferred.]


These press releases may also interest you

at 18:30
The "Digital Banking - Global Strategic Business Report" has been added to  ResearchAndMarkets.com's offering. The global market for Digital Banking estimated at US$21.1 Billion in the year 2023, is projected to reach a revised size of US$53.5...

at 18:18
NASA is awarding approximately $3.7 million to 17 museums, science centers, and other informal education institutions as part of an initiative to ignite STEM excitement. The money will go toward projects that inspire students and their learning...

at 18:15
Epiq, a global technology-enabled leader to the legal industry and corporations, announced today Epiq Facilitatortm the premier, reliable, secure application for retrieving information, managing legal analysis, and administering voluntary...

at 18:15
The "Industrial Ovens - Global Strategic Business Report" has been added to  ResearchAndMarkets.com's offering. The global market for Industrial Ovens estimated at US$10.8 Billion in the year 2023, is projected to reach a revised size of US$14.8...

at 18:15
The acquisition solidifies ValeU Group as one of the premier firms in the nation offering Fortune 500 companies and smaller...

at 18:05
CrowdStrike announced the winners of the annual CrowdStrike Asia Pacific and Japan (APJ) Partner Awards at the CrowdStrike Partner Symposium in Bangkok. The awards recognize the exceptional work the partner ecosystem accomplished, supporting...



News published on and distributed by: